Additionally, CYP1B1*2 G355T and CYP1B1*3 C4326G have also been reported to be associated with susceptibility to hormone-related cancers such as prostate cancer, bladder cancer, and carcinoma of the endometrium [18]–[20]. Here, CYP1B1 is linked to urinary bladder carcinoma.